Category:
Prophylactic Biological Products
CAS NO:
1377049-84-7
Standard:
In-house Standards,
A complex organic heteropentacyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with sofosbuvir for treatment of patients with chronic hepatitis C of all six major genotypes.
Velpatasvir is a direct-acting antiviral agent used in combination therapies for chronic hepatitis C. The core synthesis involves complex heterocyclic construction with high purity standards. Molecular formula: C28H24F2N6O4; CAS No.: 1574250-89-3.
Strictly contraindicated with specific acid-reducing agents without dose adjustment. Storage requires protection from moisture and light at controlled room temperature (20°C–25°C). Handling demands appropriate PPE to prevent inhalation or skin contact with fine powders.